Breast Cancer Tumor

Williston Hopes for Cancer Breakthrough

Williston Hopes for Cancer Breakthrough
A local dentist along with several businesses and individuals are hoping to make a cancer breakthrough. They’re doing this by giving a $100,000 donation to a doctor from Seattle Washington.

Read more on KQCD-TV Dickinson

Camp Bluebird

Camp Bluebird
What are some of the first thoughts that come to mind when you hear the word cancer? Do you sit back and smile as you daydream of boating, fishing, stand-up comedy, celebrations of life — and partying with Elvis Presley and Tina Turner?

Read more on The Daily Iberian

Cylene To Present Advances With Industry’s Only Clinical CK2 Inhibitor, CX-4945, At EORTC-NCI-AACR

Cylene To Present Advances With Industry’s Only Clinical CK2 Inhibitor, CX-4945, At EORTC-NCI-AACR
Cylene Pharmaceuticals, Inc. will present advances in the development of their first-in-class, CK2 inhibitor CX-4945, at the 22nd EORTC-NCI-AACR symposium on Molecular Targets and Cancer Therapeutics, to be held on November 16-19 in Berlin, Germany. CX-4945 is the first and only CK2 inhibitor to have entered clinical trials and represents an exciting new approach for the treatment for many …

Read more on Medical News Today

Mayo Clinic Proton Beam Therapy Program: Citing Benefits to Treating Patients with Cancer, Mayo Clinic Approves …

Mayo Clinic Proton Beam Therapy Program: Citing Benefits to Treating Patients with Cancer, Mayo Clinic Approves …
PHOENIX & ROCHESTER, Minn.–(BUSINESS WIRE)–Mayo Clinic today announced plans to establish the Mayo Clinic Proton Beam Therapy Program as part of Mayo’s national three-site cancer center in Minnesota, Arizona and Florida. The new program will employ intensity modulated proton therapy — based on pencil beam scanning — which is a more precise form of proton therapy treatment that allows greater …

Read more on Business Wire

CEO Highlights How Chronix’s Unique Blood Tests Can Enable Early Cancer Diagnosis and Personalized Treatment at Payor …

CEO Highlights How Chronix’s Unique Blood Tests Can Enable Early Cancer Diagnosis and Personalized Treatment at Payor …
Chronix Biomedical today announced that its Chief Executive Officer, Dr. Howard Urnovitz, is presenting a session on “Improving Technology for Cancer Detection and Screening” at the Payor Oncology Management Summit, a conference for healthcare insurers and providers focusing on new developments in cancer diagnosis, treatment and prevention.

Read more on Business Wire via Yahoo! Finance